Online-Ressource | |
Verfasst von: | Wang, Hui [VerfasserIn] |
Flannery, Sinead M. [VerfasserIn] | |
Dickhöfer, Sabine [VerfasserIn] | |
Huhn, Stefanie [VerfasserIn] | |
George, Julie [VerfasserIn] | |
Kubarenko, Andriy V. [VerfasserIn] | |
Lascorz, Jesus [VerfasserIn] | |
Bevier, Melanie [VerfasserIn] | |
Willemsen, Joschka [VerfasserIn] | |
Pichulik, Tica [VerfasserIn] | |
Schafmayer, Clemens [VerfasserIn] | |
Binder, Marco [VerfasserIn] | |
Manoury, Bénédicte [VerfasserIn] | |
Paludan, Søren R. [VerfasserIn] | |
Alarcon-Riquelme, Marta [VerfasserIn] | |
Bowie, Andrew G. [VerfasserIn] | |
Försti, Asta [VerfasserIn] | |
Weber, Alexander N. R. [VerfasserIn] | |
Titel: | A coding IRAK2 protein variant compromises toll-like receptor (TLR) signaling and is associated with colorectal cancer survival |
Verf.angabe: | Hui Wang, Sinead M. Flannery, Sabine Dickhöfer, Stefanie Huhn, Julie George, Andriy V. Kubarenko, Jesus Lascorz, Melanie Bevier, Joschka Willemsen, Tica Pichulik, Clemens Schafmayer, Marco Binder, Bénédicte Manoury, Søren R. Paludan, Marta Alarcon-Riquelme, Andrew G. Bowie, Asta Försti, and Alexander N.R. Weber |
E-Jahr: | 2014 |
Jahr: | June 19, 2014 |
Umfang: | 10 S. |
Teil: | volume:289 |
year:2014 | |
number:33 | |
pages:23123-23131 | |
extent:10 | |
Fussnoten: | Gesehen am 11.09.2020 |
Titel Quelle: | Enthalten in: The journal of biological chemistry |
Ort Quelle: | Bethesda, Md. : Soc., 1905 |
Jahr Quelle: | 2014 |
Band/Heft Quelle: | 289(2014), 33, Seite 23123-23131 |
ISSN Quelle: | 1083-351X |
Abstract: | Within innate immune signaling pathways, interleukin-1 receptor-associated kinases (IRAKs) fulfill key roles downstream of multiple Toll-like receptors and the interleukin-1 receptor. Although human IRAK4 deficiency was shown to lead to severe immunodeficiency in response to pyogenic bacterial infection during childhood, little is known about the role of human IRAK2. We here identified a non-synonymous IRAK2 variant, rs35060588 (coding R214G), as hypofunctional in terms of NF-κB signaling and Toll-like receptor-mediated cytokine induction. This was due to reduced ubiquitination of TRAF6, a key step in signal transduction. IRAK2 rs35060588 occurs in 3-9% of individuals in different ethnic groups, and our studies suggested a genetic association of rs35060588 with colorectal cancer survival. This for the first time implicates human IRAK2 in a human disease and highlights the R214G IRAK2 variant as a potential novel and broadly applicable biomarker for disease or as a therapeutic intervention point. |
DOI: | doi:10.1074/jbc.M113.492934 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt. Volltext ; Verlag: https://doi.org/10.1074/jbc.M113.492934 |
Volltext: http://www.jbc.org/content/289/33/23123 | |
DOI: https://doi.org/10.1074/jbc.M113.492934 | |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Colorectal Cancer |
Genetic Variant | |
Innate Immunity | |
Interleukin Receptor-associated Kinase (IRAK) | |
Signal Transduction | |
Single Nucleotide Polymorphism | |
Toll-like Receptor (TLR) | |
K10plus-PPN: | 1730477569 |
Verknüpfungen: | → Zeitschrift |